华海药业：盐酸纳洛酮注射液获得药品注册证书

Core Viewpoint - Huahai Pharmaceutical has received approval from the National Medical Products Administration for the injection of Naloxone Hydrochloride, indicating a significant advancement in its product offerings in the pharmaceutical market [1] Group 1: Product Approval - The company has been granted a drug registration certificate for Naloxone Hydrochloride injection [1] - This product is indicated for multiple uses, including antagonizing respiratory depression caused by opioid drugs during postoperative care, reversing opioid overdose, rescuing acute ethanol poisoning, and diagnosing acute opioid overdose [1]